Solubility Enhancement

Bridging the Drug Substance and Drug Product Interface

With the ability to develop both Drug Substance (DS) and Drug product (DP) under the same umbrella, our team enjoys a synergism absent in most CROs. The ability to bridge the DS/DP interface is a major competitive advantage, and we …

Scroll to Top